The roles of extracellular vesicles in cancer biology: Toward the development of novel cancer biomarkers

Proteomics

Volumn 14, Issue 4-5, 2014, Pages 412-425

  Katsuda, Takeshi ^a   Kosaka, Nobuyoshi ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Biomarker; Biomedicine; Cancer; Diagnosis; Exosome; Microvesicle

Indexed keywords

TUMOR MARKER;

ANTIANGIOGENIC ACTIVITY; BIOLOGY; BODY FLUID; CANCER BIOLOGY; CANCER DIAGNOSIS; CANCER RESEARCH; CELL COMMUNICATION; CELL VACUOLE; EXTRACELLULAR VESICLE; HUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TUMOR CELL; CANCER CELL; DIAGNOSIS; EXOSOME; NEOPLASM; NONHUMAN;

BIOMARKER; BIOMEDICINE; CANCER; DIAGNOSIS; EXOSOME; MICROVESICLE;

BIOLOGICAL TRANSPORT; CELL COMMUNICATION; EXOSOMES; HUMANS; NEOPLASMS; RNA, MESSENGER; TRANSPORT VESICLES;

EID: 84896777949     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300389     Document Type: Review

References (144)

1. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
2. Pietras, K., Ostman, A., Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 2010, 316, 1324-1331.
3. Hanahan, D., Weinberg, R. A., Hallmarks of cancer: the next generation. Cell 2011, 144, 646-674.
4. Gould, S. J., Raposo, G., As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles 2013, 2, 20389.
5. Behnke, O., An electronmicroscope study of themegacaryocyte of the rat bone marrow. I. The development of the demarcationmembrane system and the platelet surface coat. J. Ultrastruct. Res. 1968, 24, 412-433.
6. Théry, C., Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 2011, 3, 15.
7. Harding, C., Heuser, J., Stahl, P., Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell Biol. 1983, 97, 329-339.
8. Pan, B. T., Johnstone, R. M., Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell 1983, 33, 967-978.
9. Harding, C. V., Heuser, J. E., Stahl, P. D., Exosomes: looking back three decades and into the future. J. Cell Biol. 2013, 200, 367-371.
10. Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R. et al., B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183, 1161-1172.
11. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J. et al., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat. Med. 1998, 4, 594-600.
12. Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V. et al., Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 2008, 10, 619-624.
13. Peinado, H., Alečković, M., Lavotshkin, S., Matei, I. et al., Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18, 883-891.
14. Taraboletti, G., D'Ascenzo, S., Borsotti, P., Giavazzi, R. et al., Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 2002, 160, 673-680.
15. Hakulinen, J., Sankkila, L., Sugiyama, N., Lehti, K., Keski-Oja, J., Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J. Cell Biochem. 2008, 105, 1211-1228
16. Katsuda, T., Tsuchiya, R., Kosaka, N., Yoshioka, Y. et al., Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci. Rep. 2013, 3, 1197.
17. Chairoungdua, A., Smith, D. L., Pochard, P., Hull, M., Caplan, M. J., Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J. Cell Biol. 2010, 190, 1079-1091.
18. Verweij, F. J., van Eijndhoven, M. A., Hopmans, E. S., Vendrig, T. et al. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation. EMBO J. 2011, 30, 2115-2129.
19. Ratajczak, J., Miekus, K., Kucia, M., Zhang, J. et al., Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006, 20, 847-856.
20. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M. et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654-659.
21. Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A, van Eijndhoven, M. A. et al., Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. USA 2010, 107, 6328-6333.
22. Zhang, Y., Liu, D., Chen, X., Li, J. et al., Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell. 2010, 39, 133-144.
23. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F. et al., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 2010, 285, 17442-17452.
24. Biancone, L., Bruno, S., Deregibus, M. C., Tetta, C., Camussi, G., Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol. Dial. Transplant. 2012, 27, 3037-3042.
25. Katsuda, T., Kosaka, N., Takeshita, F., Ochiya, T., The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013, 13, 1637-1653.
26. Luo, S. S., Ishibashi, O., Ishikawa, G., Ishikawa, T. et al., Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol. Reprod. 2009, 81, 717-729.
27. Kosaka, N., Izumi, H., Sekine, K., Ochiya, T., microRNA as a new immune-regulatory agent in breast milk. Silence 2010, 1, 7.
28. Gutwein, P., Stoeck, A., Riedle, S., Gast, D. et al., Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 2005, 11, 2492-2501.
29. Biernat, W., Huang, H., Yokoo, H., Kleihues, P., Ohgaki, H., Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol. 2004, 14, 131-136.
30. Harris, R. C., Chung, E., Coffey, R. J., EGF receptor ligands. Exp. Cell Res. 2003, 284, 2-13.
31. Higginbotham, J. N., Demory Beckler, M., Gephart, J. D., Franklin, J. L. et al., Amphiregulin exosomes increase cancer cell invasion. Curr. Biol. 2011, 21, 779-786.
32. Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D. et al., Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 2004, 6, 507-514.
33. McCready, J., Sims, J. D., Chan, D., Jay, D. G., Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 2010, 10, 294.
34. Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H. et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10, 1470-1476.
35. Kogure, T., Lin, W. L., Yan, I. K., Braconi, C., Patel, T., Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011, 54, 1237-1248.
36. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., Schreiber, R. D., Cancer immunoediting: from immuno-surveillance to tumor escape. Nat. Immunol. 2002, 3, 991-998.
37. Dunn, G. P., Old, L. J., Schreiber, R. D., The three Es of cancer immunoediting. Annu. Rev. Immunol. 2004, 22, 329-360.
38. Wolfers, J., Lozier, A., Raposo, G., Regnault, A. et al., Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 2001, 7, 297-303.
39. Dai, S., Wan, T., Wang, B., Zhou, X. et al., More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin. Cancer Res. 2005, 11, 7554-7563.
40. Hao, S., Bai, O., Yuan, J., Qureshi, M., Xiang, J., Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell. Mol. Immunol. 2006, 3, 205-211.
41. Hao, S., Bai, O., Li, F., Yuan, J. et al., Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 2007, 120, 90-102.
42. Zeelenberg, I. S., Ostrowski, M., Krumeich, S., Bobrie, A. et al., Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res. 2008, 68, 1228-1235.
43. Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A. et al., Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005, 65, 5238-5247.
44. Andreola, G., Rivoltini, L., Castelli, C., Huber, V. et al., Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 2002, 195, 1303-1316.
45. Abusamra, A. J., Zhong, Z., Zheng, X., Li, M. et al., Tumor exosomes expressing Fas ligand mediate CD8 +T-cell apoptosis. Blood Cells Mol. Dis. 2005, 35, 169-173.
46. Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E. et al., Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 2005, 11, 1010-1020.
47. Liu, C., Yu, S., Zinn, K., Wang, J. et al., Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 2006, 176, 1375-1385.
48. Clayton, A., Mitchell, J. P., Court, J., Mason, M. D., Tabi, Z., Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Responses to interleukin-2. Cancer Res. 2007, 67, 7458-7466.
49. Ashiru, O., Boutet, P., Fernández-Messina, L., Agüera-González, S. et al., Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res. 2010, 70, 481-489.
50. Szczepanski, M. J., Szajnik, M., Welsh, A., Whiteside, T. L., Boyiadzis, M., Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. Haematologica 2011, 96, 1302-1309.
51. Xiang, X., Poliakov, A., Liu, C., Liu, Y. et al., Induction of myeloid-derived suppressor cells by tumor exosomes. Int. J. Cancer. 2009, 124, 2621-2633.
52. Chalmin, F., Ladoire, S., Mignot, G., Vincent, J. et al., Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 2010, 120, 457-471.
53. Liu, Y., Xiang, X., Zhuang, X., Zhang, S. et al., Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am. J. Pathol. 2010, 176, 2490-2499.
54. Szajnik, M., Czystowska, M., Szczepanski, M. J., Mandapathil, M., Whiteside, T. L., Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One 2010, 5, e11469.
55. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 1971, 285, 1182-1186.
56. Folkman, J., Klagsbrun, M. Angiogenic factors. Science 1987, 235, 442-447.
57. Cao, Y., Langer, R. A review of Judah Folkman's remarkable achievements in biomedicine. Proc. Natl. Acad. Sci. USA 2008, 105, 13203-13205.
58. Gesierich, S., Berezovskiy, I., Ryschich, E., Zöller, M., Systemic induction of the angiogenesis switch by the tetra-spanin D6.1A/CO-029. Cancer Res. 2006, 66, 7083-7094.
59. Nazarenko, I., Rana, S., Baumann, A., Mcalear, J. et al., Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010, 70, 1668-1678.
60. Al-Nedawi, K., Meehan, B., Kerbel, R. S., Allison, A. C., Rak, J., Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. USA 2009, 106, 3794-3799.
61. Kuhnert, F., Kirshner, J. R., Thurston, G., Dll4-Notch signaling as therapeutic target in tumor angiogenesis. Vasc. Cell 2011, 3, 20.
62. Sheldon, H., Heikamp, E., Turley, H., Dragovic, R. et al., New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010, 116, 2385-2394.
63. Kosaka, N., Iguchi, H., Hagiwara, K., Yoshioka, Y. et al., Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem. 2013, 288, 10849-10859.
64. Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T. et al., Hypoxia is important in the biology and aggression of human glial brain tumors. Clin. Cancer Res. 2004, 10, 8177-8184.
65. Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J. et al., Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10, 459-466.
66. Belting, M., Ahamed, J., Ruf, W., Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1545-1550.
67. Rak, J., Yu, J. L., Luyendyk, J., Mackman, N., Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res. 2006, 66, 10643-10646.
68. Svensson, K. J., Kucharzewska, P., Christianson, H. C., Sköld, S. et al., Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc. Natl. Acad. Sci. USA 2011, 108, 13147-13152.
69. Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J. et al., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA 2013, 110, 7312-7317.
70. Huang, X., Le, Q. T., Giaccia, A. J., MiR-210-micromanager of the hypoxia pathway. Trends Mol. Med. 2010, 16, 230-237.
71. King, H. W., Michael, M. Z., Gleadle, J. M., Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 2012, 12, 421.
72. Cirri, P., Chiarugi, P., Cancer associated fibroblasts: the dark side of the coin. Am. J. Cancer Res. 2011, 1, 482-497.
73. Tlsty, T. D., Coussens, L. M., Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 2006, 1, 119-150.
74. Thiery, J. P., Acloque, H., Huang, R. Y. J., Nieto, M. A., Epithelial-mesenchymal transitions in development and disease. Cell. 2009, 139, 871-890.
75. Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A. et al., Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151, 1542-1556.
76. Roorda, B. D., ter Elst, A., Kamps, W. A., de Bont, E. S., Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit. Rev. Oncol. Hematol. 2009, 69, 187-198.
77. Zhu, W., Huang, L., Li, Y., Zhang, X. et al., Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012, 315, 28-37.
78. Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K. et al., BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J. Clin. Invest. 2013, 123, 1542-1555.
79. Kosaka, N., Iguchi, H., Yoshioka, Y., Hagiwara, K. et al., Competitive interactions of cancer cells and normal cells via secretory microRNAs. J. Biol. Chem. 2011, 287, 1397-1405.
80. Putz, U., Howitt, J., Doan, A., Goh, C. P. et al., The tumor suppressor PTEN is exported in exosomes and has phosphatase activity in recipient cells. Sci. Signal. 2012, 5, ra7.
81. Gabriel, K., Ingram, A., Austin, R., Kapoor, A. et al., Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer. PLoS One. 2013, 8, e70047.
82. Vong, S., Kalluri, R., The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer 2011, 2, 1139-1145.
83. Webber, J., Steadman, R., Mason, M. D., Tabi, Z., Clayton, A., Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010, 70, 9621-9630.
84. Cho, J. A., Park, H., Lim, E. H., Kim, K. H. et al., Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol. Oncol. 2011, 123, 379-386.
85. Cho, J. A., Park, H., Lim, E. H., Lee, K. W., Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int. J. Oncol. 2012, 40, 130-138.
86. Jung, T., Castellana, D., Klingbeil, P., Cuesta Hernández, I. et al., CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009, 11, 1093-1105.
87. Rana, S., Malinowska, K., Zöller, M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013, 15, 281-295.
88. Grange, C., Tapparo, M., Collino, F., Vitillo, L. et al., Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011, 71, 5346-5356.
89. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H. et al., VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438, 820-827.
90. Garnier, D., Magnus, N., Lee, T. H., Bentley, V. et al., Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J. Biol. Chem. 2012, 287, 43565-43572.
91. Garnier, D., Magnus, N., Meehan, B., Kislinger, T., Rak, J., Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Exp. Cell Res. 2013, 319, 2747-2757.
92. Tauro, B. J., Mathias, R. A., Greening, D. W., Gopal, S. K. et al., Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol. Cell. Proteomics 2013, 12, 2148-2159.
93. Meckes, D. G., Gunawardena, H. P., Dekroon, R. M., Heaton, P. R. et al., Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc. Natl. Acad. Sci. USA 2013, 110, E2925-E2933.
94. Tauro, B. J., Greening, D. W., Mathias, R. A., Mathivanan, S. et al., Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol. Cell. Proteomics 2013, 12, 587-598.
95. Epple, L. M., Griffiths, S. G., Dechkovskaia, A. M., Dusto, N. L. et al., Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS One 2012, 7, e42064.
96. Choi, D. S., Choi, D. Y., Hong, B. S., Jang, S. C. et al., Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells. J. Extracell. Vesicles 2012, 1, 18704.
97. Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A. et al., Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One 2013, 8, e75054.
98. Park, J. O., Choi, D. Y., Choi, D. S., Kim, H. J. et al., Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 2013, 13, 2125-2134.
99. Catalona, W. J., Management of cancer of the prostate. N. Engl. J. Med. 1994, 331, 996-1004.
100. Taylor, D. D., Gercel-Taylor, C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 2008, 110, 13-21.
101. Logozzi, M., De Milito, A., Lugini, L., Borghi, M. et al., High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009, 4, e5219.
102. Lu, Q., Zhang, J., Allison, R., Gay, H. et al., Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate 2009, 69, 411-418.
103. Nilsson, J., Skog, J., Nordstrand, A., Baranov, V. et al., Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer 2009, 100, 1603-1607.
104. Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., Kloecker, G. H., Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 2009, 10, 42-46.
105. Taylor, D. D., Gercel-Taylor, C., Parker, L. P., Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer. Gynecol. Oncol. 2009, 115, 112-120.
106. Choi, D. S., Park, J. O., Jang, S. C., Yoon, Y. J. et al., Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 2011, 11, 2745-2751.
107. Tavoosidana, G., Ronquist, G., Darmanis, S., Yan, J. et al., Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 8809-8814.
108. Bryant, R. J., Pawlowski, T., Catto, J. W., Marsden, G. et al., Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 2012, 106, 768-774.
109. Khan, S., Jutzy, J. M., Valenzuela, M. M., Turay, D. et al., Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One 2012, 7, e46737.
110. Murakami, Y., Toyoda, H., Tanahashi, T., Tanaka, J. et al., Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One 2012, 7, e48366.
111. Shao, H., Chung, J., Balaj, L., Charest, A. et al., Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 2012, 18, 1835-1840.
112. Noerholm, M., Balaj, L., Limperg, T., Salehi, A. et al., RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 2012, 12, 22.
113. Tanaka, Y., Kamohara, H., Kinoshita, K., Kurashige, J. et al., Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 2013, 119, 1159-1167.
114. Lau, C, Kim, Y, Chia, D, Spielmann, N. et al., Role of pancreatic cancer-derived exosomes in salivary biomarker development. J. Biol. Chem. 2013, 288, 26888-26897.
115. Kosaka, N., Iguchi, H., Ochiya, T., Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010, 101, 2087-2092.
116. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B. et al., Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141, 672-675.
117. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R. et al., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
118. Momburg, F., Moldenhauer, G., Hämmerling, G. J., Möller, P., Immunohistochemical study of the expression of a Mr 34, 000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res. 1987, 47, 2883-2891.
119. Hessvik, N. P., Phuyal, S., Brech, A., Sandvig, K., Llorente, A., Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim. Biophys. Acta 2012, 1819, 1154-1163.
120. Runz, S., Keller, S., Rupp, C., Stoeck, A. et al., Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 2007, 107, 563-571.
121. Mathivanan, S., Lim, J. W., Tauro, B. J., Ji, H. et al., Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 2010, 9, 197-208.
122. Ji, H., Greening, D. W., Barnes, T. W., Lim, J. W. et al., Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013, 13, 1672-1686.
123. Nakahara, T, Kita, A, Yamanaka, K, Mori, M. et al., YM155, a novel small-molecule survivin suppressant, induces regression of established human hormone-refractory prostate tumor xenografts. Cancer Res. 2007, 67, 8014-8021.
124. Khan, S., Jutzy, J. M., Aspe, J. R., McGregor, D. W. et al., Survivin is released from cancer cells via exosomes. Apoptosis 2011, 16, 1-12.
125. Di Vizio, D., Morello, M., Dudley, A. C., Schow, P. W. et al., Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am. J. Pathol. 2012, 181, 1573-1584.
126. Di Vizio, D., Kim, J., Hager, M. H., Morello, M. et al., Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res. 2009, 69, 5601-5609.
127. Kosaka, N., Takeshita, F., Yoshioka, Y., Hagiwara, K. et al., Exosomal tumor-suppressive microRNAs as novel cancer therapy: "exocure" is another choice for cancer treatment. Adv. Drug Deliv. Rev. 2013, 65, 376-382.
128. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C. et al., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 2011, 29, 341-345.
129. Ohno, S., Takanashi, M., Sudo, K., Ueda, S. et al., Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol. Ther. 2013, 21, 185-191.
130. Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L. et al., Ceramide triggers budding of exosome vesicles into multi-vesicular endosomes. Science 2008, 319, 1244-1247.
131. Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I. et al., Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 2010, 12, 19-30.
132. Hsu, C., Morohashi, Y., Yoshimura, S., Manrique-Hoyos, N. et al., Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J. Cell Biol. 2010, 189, 223-232.
133. Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., Sanderson, R. D., Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 2013, 288, 10093-10099.
134. Jimenez, C. R., Knol, J. C., Meijer, G. A., Fijneman, R. J., Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J. Proteomics 2010, 73, 1873-1895.
135. Welton, J. L., Khanna, S., Giles, P. J., Brennan, P. et al., Proteomics analysis of bladder cancer exosomes. Mol. Cell Proteomics 2010, 9, 1324-1338.
136. Lau, C. S., Wong, D. T., Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS One 2012, 7, e33037.
137. Palazzolo, G., Albanese, N. N., DI Cara, G., Gygax, D. et al., Proteomic analysis of exosome-like vesicles derived from breast cancer cells. Anticancer Res. 2012, 32, 847-860.
138. Ji, H., Greening, D. W., Barnes, T. W., Lim, J. W. et al., Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013, 13, 1672-1686.
139. Pigati, L., Yaddanapudi, S. C., Iyengar, R., Kim, D. J. et al., Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One 2010, 5, e13515.
140. Hessvik, N. P., Phuyal, S., Brech, A., Sandvig, K., Llorente A., Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Biochim. Biophys. Acta 2012, 1819, 1154-1163.
141. Goda, T., Masuno, K., Nishida, J., Kosaka, N. et al., A label-free electrical detection of exosomal microRNAs using microelectrode array. Chem. Commun. (Camb.) 2012, 48, 11942-11944.
142. Witwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A. et al., Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles 2013, 2, 20360.
143. Raposo, G., Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200, 373-383.
144. Yoshioka, Y., Konishi, Y., Kosaka, N., Katsuda et al., Comparative marker analysis of extracellular vesicles in different human cancer types. J. Extracell. Vesicles 2013, 2, 20424.